Table 4 Risk of death regarding CD14 rs2569190 polymorphism in septic shock patients who underwent major cardiac or abdominal surgery.

From: Association of CD14 rs2569190 polymorphism with mortality in shock septic patients who underwent major cardiac or abdominal surgery: A retrospective study

  Univariate Multivariate
HR 95%CI p-value aHR 95%CI p-value(*)
The first 28 days
 rs2569190 GG 1.50 0.92; 2.45 0.101 1.55 0.95; 2.53 0.077
 Emergency surgery     1.86 1.00; 3.46 0.049
 APACHE-II score     1.04 1.00; 1.08 0.067
 Peritonitis     2.28 1.35; 3.85 0.002
 Heart disease     1.97 1.20; 3.22 0.007
The first 60 days
 rs2569190 GG 1.54 1.02; 2.33 0.039 1.67 1.10; 2.54 0.016
 Emergency surgery     1.86 1.18; 2.92 0.007
 Peritonitis     1.84 1.19; 2.86 0.006
 Heart disease     1.72 1.13; 2.63 0.012
 Liver disease     1.91 0.82; 4.47 0.133
The first 90 days
 rs2569190 GG 1.50 1.00; 2.26 0.050 1.64 1.08; 2.48 0.020
 Emergency surgery     1.89 1.21; 2.95 0.005
 Peritonitis     1.83 1.18; 2.82 0.007
 Heart disease     1.70 1.12; 2.58 0.012
 Liver disease     1.92 0.82; 4.47 0.132
  1. (*)P-values were calculated by Cox regression adjusting for the most important clinical and epidemiological characteristics (see statistical analysis section).
  2. Abbreviations: CD14, cluster of differentiation 14; HR, hazard ratio; aHR, adjusted hazard ratio; 95%CI, 95% confidence interval; p-value, level of significance.